EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost-Effectiveness of Corneal Collagen Crosslinking for Progressive Keratoconus: A Brazilian Unified Health System Perspective

Lucca Ortolan Hansen iD, Renato Garcia iD, André Augusto Miranda Torricelli iD, Samir Jacob Bechara

International Journal of Environmental Research and Public Health · 2024

DOI: 10.3390/ijerph21121569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2024. Verfasst von Lucca Ortolan Hansen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Ophthalmology, School of Medicine, University of São Paulo, São Paulo 01246-903, SP, Brazil. Hauptthemen laut MEDLINE: Keratoconus, Collagen, Cost-Benefit Analysis, Quality-Adjusted Life Years. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Keratoconus is a burden to health systems and patients worldwide. Corneal collagen crosslinking (CXL) treatment has been shown abroad to be cost-effective for treating progressive keratoconus. However, no cost-effectiveness studies have been performed in Brazil. The aim of this study was to assess the cost-effectiveness of corneal collagen crosslinking (CXL) compared with the conventional treatment for progressive keratoconus from the Brazilian Unified Health System (SUS) payer’s perspective. A lifetime microsimulation model was utilized to compare the lifetime costs and quality-adjusted life years for patients undergoing corneal collagen CXL or conventional treatment. Two groups of 5000 18-year-old patients were simulated, with one group receiving corneal CXL at the outset and the control group remaining untreated. The TreeAge Pro Healthcare 2024 software was used for modeling and analysis. Corneal collagen CXL demonstrated superior cost-effectiveness compared to the conventional treatment, with an incremental cost-effectiveness ratio of 58.26 USD/quality-adjusted life years (QALY) gained (95% CI: 58.17–58.36) and a positive incremental net monetary benefit of USD 11,613.82 (95% CI: 11,605.66–11,621.99). CXL significantly reduced the number of required corneal transplants, with a mean of 968.8 (95% CI: 959–978.58) fewer transplants per 10,000 eyes treated. The variable with the most significant impact on the incremental net monetary benefit was the duration of the CXL effect. This study concluded that corneal CXL is a highly cost-effective intervention for progressive keratoconus within the Brazilian SUS. These findings advocate for broader accessibility to this vision-saving treatment within the SUS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeratoconusCollagenCost-Benefit AnalysisQuality-Adjusted Life YearsHumansBrazilAdolescentMaleCross-Linking ReagentsUltraviolet RaysCorneaPhotosensitizing Agents

Stichwörter der Autor:innen

Brazilian Unified Health SystemSUScorneal crosslinkingcost-effectivenessincremental cost-effectiveness ratioincremental net monetary benefitkeratoconusquality-adjusted life years

Substanzen

CollagenCross-Linking ReagentsPhotosensitizing Agents

Autor:innen und Institutionen

  • Division of Ophthalmology, School of Medicine, University of São Paulo, São Paulo 01246-903, SP, Brazil.

ORCID-Profile: Lucca Ortolan Hansen, Renato Garcia, André Augusto Miranda Torricelli

Zitieren

APA

Hansen, L. O., Garcia, R., Torricelli, A. A. M., & Bechara, S. J. (2024). Cost-Effectiveness of Corneal Collagen Crosslinking for Progressive Keratoconus: A Brazilian Unified Health System Perspective. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph21121569

Vancouver

Hansen LO, Garcia R, Torricelli AAM, Bechara SJ. Cost-Effectiveness of Corneal Collagen Crosslinking for Progressive Keratoconus: A Brazilian Unified Health System Perspective. International Journal of Environmental Research and Public Health. 2024. doi:10.3390/ijerph21121569

BibTeX
@article{Hansen2024,
  author = {Hansen, Lucca Ortolan and Garcia, Renato and Torricelli, André Augusto Miranda and Bechara, Samir Jacob},
  title = {Cost-Effectiveness of Corneal Collagen Crosslinking for Progressive Keratoconus: A Brazilian Unified Health System Perspective},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2024},
  doi = {10.3390/ijerph21121569}
}
Kostenlos starten →